McCabe Cathleen

Ahmed Iqbal Ike K, De Francesco Ticiana, Rhee Douglas, McCabe Cathleen, Flowers Brian, Gazzard Gus et al.

The HORIZON trial found that adding a Schlemm's canal microstent to cataract surgery significantly improved long-term IOP control, reduced medication use, and lowered the need for further glaucoma surgery compared to cataract surgery alone.

Fram Nicole R, Bedrood Sahar, Durr Georges M, Liaboe Chase A, Samuelson Thomas W, Shah Manjool et al.

A patient developed a 2.0D myopic surprise after cataract surgery with microstent implantation, likely due to anterior segment changes, highlighting the need for careful evaluation in complex glaucoma cases.

Jones Jason, Koch Douglas D, Vold Steven, McCabe Cathleen, Rhee Douglas, Lewis Richard et al.

A study of a Schlemm canal microstent with cataract surgery for glaucoma found it significantly reduced eye pressure and medication use more than cataract surgery alone, offering a safe, effective combined treatment.